select a format

Single User License
USD 1200 INR 76908
Hard Copy License
USD 1600 INR 102544
Corporate User License
USD 2400 INR 153816

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"


India Diagnostic Laboratories Market Outlook to 2021  Growing Prevalence of Diseases and Launch of Technologically Advanced Procedures to Drive Growth

India Diagnostic Laboratories Market Outlook to 2021 Growing Prevalence of Diseases and Launch of Technologically Advanced Procedures to Drive Growth


  • Products Id :- KR463
  • |
  • Pages: 105
  • |
  • February 2017
  • |
  • |
  Request for Sample Report

Executive Summary

Ken Research announced its latest publication on "India Diagnostic Laboratories Market Outlook to 2021 - Growing Prevalence of Diseases and Launch of Technologically Advanced Procedures to Drive Growth" provides a comprehensive analysis of the diagnostic laboratories market. The report includes the cumulative revenue generated by the market players from diagnostic services including both government and private diagnostic laboratories. The private diagnostic laboratories has been further explained with details on market share contributed by pathology tests and radiology tests, by Tier I, Tier II and Tier III Cities, and by hospital based diagnostic laboratories, polyclinics and independent diagnostic laboratories operating in India. The share by organized and unorganized players has also been provided in detail to clearly explain the present competition scenario in the market. The stakeholders of this report include diagnostic laboratories market players, laboratories equipments providers, companies involved in research and development activities, and the new entrants and venture capitalists who wish to invest in diagnostic laboratories market in future. Detailed snapshot on pathology tests market and radiology tests market is included in the report to elucidate facts about the market in detail. Various marketing analysis factors such as trends and developments, regulatory framework and Porter's five forces analysis are also added in the study for clear understanding about the factors responsible for present scenario of the market. The future analysis of overall India diagnostic laboratories market has also been discussed along with recommendations from analyst view.

A phenomenal increase in Indian population over the years along with the rise in number of infectious diseases in the country acted as a driver for diagnostic laboratories market. The diagnostic laboratories market was recorded as INR ~ crore in FY'2016 exhibiting growth from INR ~ crore in FY'2011. Increasing healthcare expenditure, rising adoption of preventive health check-ups, surging popularity of medical tourism in the country and healthcare infrastructural developments in Tier II and Tier III cities are other major factors which have augmented the growth of diagnostic laboratories market in India.

On the basis of type of tests, Pathology tests dominated the market with revenue share of ~% earned by the overall private diagnostic laboratories in the country in FY'2016. However, radiology laboratories have witnessed growth at a rapid pace recording CAGR of ~% from FY'2011 to FY'2016. Pathology testing being first line of diagnosis for majority of diseases is the major factor which resulted in dominant position of the segment in the market, catering to the needs of the patients. Biochemical testing of blood sugar level becomes a mandatory recommendation by the doctors after every regular interval of time owing to the growing prevalence of diabetes in the nation while for the diagnosis of cardiovascular disease lipid profiles play a similar role.

Tier I cities contributed majority part of revenue share to the total revenue earned by the India private diagnostic laboratories market in FY'2016. Rise in pollution levels in Tier I cities has further increased the chances of more severe diseases being spread across the masses, thereby resulting in more demand for diagnostic services. Moreover, high awareness among the educated people living in these cities resulting in more number of preventive healthcare testing has added to the revenue of overall diagnostic laboratories market making segment dominate the market. Additionally, prices of tests are more in large cities as compared to Tier II and Tier III cities, which obligate the people to get services at the available prices as a necessity to diagnose a disease.

By type of players, lack of entry barrier and absence of strong regulation in diagnostics market has led to an increase in number of unorganized players which mostly adds to the standalone diagnostic centers in the country. The unorganized segment contributed around ~% of the diagnostic services market in terms of revenue in FY'2016. Such players prove useful in catering to the diagnostic needs of Tier II and Tier III cities, where almost every area has a diagnostic laboratory, particularly dealing in pathology services.

Competitive Scenario
India diagnostic laboratories market has a limited number of organized players and the overall market is driven by the unorganized laboratories in the country. Merger with Fortis Healthcare was the major driving force that helped SRL Diagnostics maintain majority share in pathology tests market. The merger helped the laboratory in gaining revenue as it added the revenue generated by inpatient's staying in the Fortis Hospital. The introduction of MySRL application, where customers can book a test as per their convenience and pay online for the services, further augmented the growth of SRL diagnostics.

SRL Diagnostic further is observed to lead in radiology tests market as well with a revenue share of ~% in FY'2016. Dr Lal PathLabs followed SRL with a share of ~% in the revenue earned by overall radiology tests market in India in FY'2016. Being India's first player that has introduced laboratory services under Public Private Partnership with Government of Tripura, helped Dr Lal PathLabs extend its radiology services to people in Tier II and Tier III cities. Therefore, having the first mover advantage to be associated with the Government created trust among the people about the lab, making Dr Lal PathLabs mark revenue of INR ~ crore in FY'2016.

Key Topics Covered in the Report:

  • The market size of India Diagnostic Laboratories Market by Revenues
  • By Government and Privately Owned Diagnostic Laboratories
  • Market segmentation of India Private Diagnostic Laboratories Market by Pathology and Radiology Tests, by Hospital Based Diagnostic Laboratories, Polyclinics and Independent Diagnostic Laboratories and by Tier I, Tier II and Tier III Cities
  • Snapshot on India Private Pathology and Radiology Tests Market
  • Porter's Five Forces Analysis for India Private Diagnostic Laboratories Market
  • Trends and Developments in India Private Diagnostic Laboratories Market
  • Decision Making Process for Choosing Diagnostic Laboratories
  • Investment Model for Setting up Diagnostic Laboratory in India
  • Competitive landscape and Detailed Company Profiles of Major Market Players
  • Future Outlook and Projections of India Private Diagnostic Laboratories Market
  • Analyst Recommendations
  • Macro-economic Factors Impacting India Private Diagnostic Laboratories Market


Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

1. Executive Summary
Market Potential
Market Segmentation for Private Diagnostic Laboratories
Competitive Landscape
Future Analysis And Projections
2. Research Methodology
2.1. Market Definitions
2.2. Abbreviations
2.3. Market Size and Modeling
Approach – Market Sizing
Variables (Dependent and Independent)
Multi Factor Based Sensitivity Model
Limitations
3. India Diagnostic Laboratories Market Introduction
4. Operating Models Followed by India Diagnostic Laboratories Market
4.1. Hub-and-Spoke Model
5. India Diagnostic Laboratories Market Size and Growth, FY'2011-FY'2016
5.1. By Revenue, FY'2011-FY'2016
5.2. By Government and Privately Owned Diagnostic Laboratories
6. India Private Diagnostic Laboratories Market Segmentation
6.1. By Pathology and Radiology Tests
6.2. By Hospital Based Diagnostic Laboratories, Polyclinics and Independent Diagnostic Laboratories
6.3. By Tier I, Tier II, and Tier III Cities, FY'2016
6.4. By Organized and Unorganized Players
7. Snapshot on India Private Pathology Tests Market
7.1. India Private Pathology Tests Market Size By Revenue, FY'2011 – FY'2016
7.2. India Pathology Tests Market Segmentation By Type of Pathology
7.3. Market Share of Major Players in Private Pathology Tests Market by Revenue, FY'2016
8. Snapshot on India Private Radiology Tests Market
8.1. India Private Radiology Tests Market Size By Revenue, FY'2011 – FY'2016
8.2. India Private Radiology Tests Market Segmentation By Type of Tests, FY'2016
8.3. Market Share of Major Players in Radiology Tests Market By Revenue, FY'2016
9. Decision Making Process of Customers for Choosing Diagnostic Laboratories
10. Trends and Developments in India Private Diagnostic Laboratories Market
10.1. Advancements in Technology
10.2. Collaboration of Diagnostic Healthcare Service Providers with Corporate Entities
10.3. Increasing Penetration of Medical Insurance
10.4. Rising Investments By Private Players And Venture Capitalists
10.5. Improving Telemedicine Industry for Diagnosis
11. Investment Model for Setting Up a Diagnostic Laboratory
12. Regulatory Environment for India Diagnostic Laboratories Market
12.1. Licenses and Other Regulations
Preconception and Pre-Natal Diagnostic Techniques Act, 1994
13. Porter's Five Forces Analysis for India Private Diagnostic Laboratories Market
14. Company Profiles For India Diagnostic Laboratories Market
14.1. SRL Diagnostics
14.2. Dr. Lal Pathlabs
14.3. Metropolis Healthcare Limited
14.4. Medall Healthcare Pvt. Ltd.
14.5. Thyrocare Technologies Limited
14.6. Apollo Health and Lifestyle Limited
14.7. BSR Healthcare
15. India Private Diagnostic Laboratories Market Future Outlook and Projections, FY'2017 – FY'2021
India Private Diagnostic Laboratories Market Future Outlook and Projections by Radiology and Pathology Tests
India Private Diagnostic Laboratories Market Future Outlook and Projections by Tier I, Tier II and Tier III Cities, fy'2017-fy'2021
India Private Diagnostic Laboratories Market Future Outlook and Projections by Organized and Unorganized Players, fy'2017-fy'2021
16. Analyst Recommendations
17. Macro Economic Variables Impacting Private Diagnostics Laboratories Market in India
17.1. Per Capita Healthcare Spending in India, FY'2011-FY'2021
17.2. Ageing population in India, 2011 - 2021
17.3. Number of births in India, 2011-2021
17.4. Medical Tourism in India, 2011-2021
Disclaimer
Contact Us

Figure 4-1: Hub-and-Spoke Model Followed by Diagnostic Chains
Figure 4-2: Logistics Functioning In Hub-and-Spoke Model
Figure 5-1: India Diagnostic Laboratories Market on the basis of Revenue in INR Crore, FY'2011 - FY'2016
Figure 5-2: India Diagnostic Laboratories Market by Government and Privately owned Laboratories on the basis of Revenue in Percentage, FY'2011 - FY'2016
Figure 6-1: India Private Diagnostic Laboratories Market Segmentation by Pathology Tests and Radiology Tests on the basis of Revenue in terms of Percentage, FY'2011 – FY'2016
Figure 6-2: India Private Diagnostic Laboratories Market Segmentation by Hospital based Diagnostic Laboratories, Polyclinics and Independent Diagnostic Laboratories on the basis of Revenue in Percentage, FY'2011 – FY'2016
Figure 6-3: India Private Diagnostic Laboratories Market Segmentation by Tier Cities (Tier I, Tier II, Tier III) on the basis of Revenue in Percentage, FY'2011 – FY'2016
Figure 6-4: India Private Diagnostic Laboratories Market Segmentation by Organized and Unorganized Players on the basis of Revenue in Percentage, FY'2011 – FY'2016
Figure 7-1: India Private Pathology Tests Market Size on the basis of Revenue in INR Crore, FY'2011 - FY'2016
Figure 7-2: India Private Pathology Tests Market Segmentation by Type of Pathology Tests (Clinical Biochemistry, Hematology, Surgical Pathology, Histopathology, Clinical Microbiology, Molecular Biology) on the Basis of Revenue in Percentage, FY'2016
Figure 7-3: Market Share of Major Players (SRL Diagnostics, Dr Lal PathLabs, Metropolis, Medall Diagnostics, Thyrocare, Pathcare Labs, Suburban Diagnostics, and others) in Private Pathology Tests Market on the Basis of Revenue in Percentage, FY'2016
Figure 8-1: India Private Radiology Tests Market Size by Revenue in INR Crore, FY'2011 – FY'2016
Figure 8-2: India Private Radiology Tests Market Segmentation by Type of Tests (X-Ray, Sonography, MRI, CT Scan, Mammography, PET/SPECT) on the basis of Revenue in Percentage, FY'2016
Figure 8-3: India Private Radiology Tests Market Share of Major Players (SRL Diagnostics, Dr Lal PathLabs, Metropolis, Thyrocare, BSR Healthcare and others) on the basis of Revenue in Percentage, FY'2016
Figure 10-1: Medical Insurance Market in India on the Basis of Premium in INR Crore, FY'2012 - FY'2016
Figure 13-1: Porter's Five Forces Analysis for India Private Diagnostic Laboratories Market
Figure 14-1: Financial Performance of SRL Diagnostics on the basis of Total Revenue in INR Crore, FY'2014-FY'2016
Figure 14-2: Financial Performance of Dr. Lal PathLabs Limited on the basis of Total Revenue in INR Crore, FY'2014-FY'2016
Figure 14-3: Financial Performance of Metropolis Healthcare on the basis of Total Revenue in INR Crore, FY'2014-FY'2016
Figure 14-4: Medall Healthcare Financial Performance on the Basis of Net Revenues in INR Crore, FY'2014–FY'2016
Figure 14-5: Financial Performance of Thyrocare Technologies Limited on the basis of Total Revenue in INR Crore, FY'2014-FY'2016
Figure 14-6: Operational Performance of Thyrocare Technologies Limited on the basis of Samples Processed (‘000), FY'2012-FY'2016
Figure 14-7: Apollo Health and Lifestyle Limited Financial Performance on the Basis of Net Revenues in INR Crore, FY'2014–FY'2016
Figure 14-8: BSR Healthcare Financial Performance on the Basis of Net Revenues from Diagnostic Services in INR Crore, FY'2014 – FY'2016
Figure 15-1: : Future Outlook and Projections for India Diagnostic Laboratories Market on the basis of Revenue in INR Crore, FY'2017-FY'2021
Figure 15-2: India Private Diagnostic Laboratories Market Segmentation Future Outlook and Projection by Pathology and Radiology Tests on the Basis of Revenue in Percentage, FY'2017-FY'2021
Figure 15-3: India Private Diagnostic Laboratories Market Segmentation Future Outlook and Projection by Tier I, Tier II and Tier III Cities on the Basis of Revenue in Percentage, FY'2017-FY'2021
Figure 15-4: India Private Diagnostic Laboratories Market Segmentation Future Outlook and Projection by Organized and Unorganized Players on the Basis of Revenue in Percentage, FY'2017-FY'2021
Figure 17-1: Per Capita Healthcare Spending in India in INR Crore, 2011-2021
Figure 17-2: Ageing Population of India in Crore, 2011 - 2021
Figure 17-3: Number of Births in India in Millions, 2011 – 2021
Figure 17-4: Medical Tourism Market in India in INR Billion, FY'2011 – FY'2021

Table 2-1: Correlation Matrix for India Diagnostic Laboratories Market
Table 2-2: Regression Coefficients Output
Table 3-1: India Healthcare Statistics on the basis of Health Parameters
Table 3-2: Top Ten Causes of Deaths and Number of Deaths in India, 2014
Table 4-1: Rationale for Business Models Followed by Private Diagnostic Laboratories Market in India
Table 4-2: Components of Hub-and-Spoke Model
Table 5-1: Rationale for India Diagnostic Laboratories Market on the basis of Revenue, FY'2011 - FY'2016
Table 5-2: Rationale for India Diagnostic Laboratories Market Size on the Basis of Government and Privately owned Laboratories
Table 5-3: Comparative Prices for Key Diagnostic Tests in Government Owned and Privately Owned Laboratories, 2016
Table 5-4: India Diagnostic Laboratories Market by Government and Privately owned Laboratories on the basis of Revenue in INR Crore, FY'2011 - FY'2016
Table 6-1: Rationale for India Private Diagnostic Laboratories Market Segmentation by Pathology Tests and Radiology Tests, FY'2011 – FY'2016
Table 6-2: India Private Diagnostic Laboratories Market Segmentation by Pathology Tests and Radiology Tests on the basis of Revenue in terms of INR Crore, FY'2011 – FY'2016
Table 6-3: Rationale for India Private Diagnostic Laboratories Market Segmentation by Hospital based Diagnostic Laboratories, Polyclinics and Independent Diagnostic Laboratories, FY'2011 – FY'2016
Table 6-4: India Private Diagnostic Laboratories Market Segmentation by hospital based diagnostic laboratories, polyclinics and Independent Diagnostic Laboratories on the Basis of Revenue in INR Crore, FY'2011 – FY'2016
Table 6-5: Rationale for India Private Diagnostic Laboratories Market Segmentation by Tier Cities (Tier I, Tier II and Tier III), FY'2011 – FY'2016
Table 6-6: India Private Diagnostic Laboratories Market Segmentation by Tier Cities (Tier I, Tier II, Tier III) on the basis of Revenue in INR Crore, FY'2011 – FY'2016
Table 6-7: Rationale for India Private Diagnostic Laboratories Market Segmentation by Organized and Unorganized Player, FY'2011 – FY'2016
Table 6-8: Major Organized Players in India Private Laboratories Market and their Presence across India, 2016
Table 6-9: India Private Diagnostic Laboratories Market Segmentation by Organized and Unorganized Player on the Basis of Revenue in INR Crore, FY'2011 – FY'2016
Table 7-1: Rationale for Private Pathology Tests Market Segmentation by Type of Pathology Tests (Clinical Biochemistry, Hematology, Surgical Pathology, Histopathology, Clinical Microbiology and Molecular Biology), FY'2016
Table 7-2: Major Tests included in Pathology Tests Market
Table 7-3: Private Pathology Tests Market Segmentation by Type of Pathology Tests (Clinical Biochemistry, Hematology, Surgical Pathology, Histopathology, Clinical Microbiology, Molecular Biology) on the Basis of Revenue in INR Crore, FY'2016
Table 7-4: Rationale for India Private Pathology Tests Market Share by Major Players (SRL Diagnostics, Dr Lal PathLabs, Metropolis, Medall Diagnostics, Thyrocare and others), FY'2016
Table 7-5: Market Share of Major Players (SRL Diagnostics, Dr Lal PathLabs, Metropolis, Medall Diagnostics, Thyrocare and others) in Private Pathology Tests Market on the Basis of Revenue in INR Crore, FY'2016
Table 8-1: Rationale for India Private Radiology Tests Market Segmentation by Type of Tests (X-Ray, Sonography, MRI, CT Scan, Mammography, PET/SPECT), FY'2016
Table 8-2: India Private Radiology Tests Market Segmentation by Type of Tests (X-Ray, Sonography, MRI, CT Scan, Mammography, PET/SPECT) on the basis of Revenue in INR Crore, FY'2016
Table 8-3: Rationale for India Private Radiology Tests Market Share by Major Players (SRL Diagnostics, Dr Lal PathLabs, Metropolis, Thyrocare, BSR Healthcare and others), FY'2016
Table 8-4: India Private Radiology Tests Market Share of Major Players on the basis of Revenue in INR Crore, FY'2016
Table 9-1: Rationale for Decision Making Process of Customers for choosing a Diagnostic Laboratory
Table 9-2: Sample Composition for Decision Making Process for Choosing Diagnostic Laboratory in India
Table 10-1: Private Diagnostic Laboratories Players and Key Investors
Table 11-1: Parameters for Setting up a Franchise of Dr. Lal PathLabs in India
Table 11-2: Equipment Expenditure for Pathology Laboratories in India
Table 11-3: Equipment Expenditure for Radiology Laboratories in India
Table 11-4: Total Fixed Cost for Setting up a Diagnostic Laboratory in India
Table 11-5: Annual Salaries of Diagnostic Laboratories Professionals on the basis of Salaries per Profession in terms of INR in India
Table 11-6: Annual Human Resource Expenses in terms of INR in India
Table 11-7: Annual Expenses of Franchised Diagnostic Laboratory of Dr. Lal PathLabs in India
Table 11-8: Means of Finance for Setting up a Franchised Diagnostic laboratory of Dr Lal PathLabs in India
Table 11-9: Annual Operating Expenses of a Franchised Diagnostic laboratory of Dr Lal PathLabs in India
Table 11-10: Financial Indicators Related to Franchised Diagnostic laboratory of Dr Lal PathLabs in India
Table 12-1: Process and Conditions for Setting up Diagnostic Laboratories under the Clinical Establishment Act, 2010
Table 13-1: Porter's Five Forces Analysis for India Private Diagnostic Laboratories Market
Table 14-1: Company Profile of SRL Diagnostics including Company Overview, USP, Services Portfolio , Number of Locations, Number of Centers, Number of Tests, Service Portfolio, Business Strategies and Number of employees
Table 14-2: Company Profile of Dr. Lal Pathlabs including Company Overview, USP, Number of Locations, Number of Tests, Service Portfolio, Business Strategies and Number of Employees
Table 14-3: Company Profile of Metropolis Healthcare including Company Overview, USP, Number of Locations, Number of Centers, Number of Tests, Service Portfolio, Business Strategies and Number of Employees
Table 14-4: Company Profile for Medall Healthcare Pvt. Ltd. including Company Overview, Business Strategies, USP, Service Portfolio, Number of Diagnostic Centers, Number of Tests Conducted, Locations and Number of Employees
Table 14-5: Company Profile of Thyrocare Technologies Limited including Company Overview, USP, Number of Locations, Number of Tests, Services Portfolio, Number of Centers, Business Strategies, Number of Employees and Franchisee /own center setup route
Table 14-6: Company Profile for Apollo Health and Lifestyle Limited (AHLL) including Company Overview, Business Strategies, USP, Service Portfolio, and Locations
Table 14-7: Company Profile of BSR Healthcare including Company Overview, Business Strategies, USP, Service Portfolio, Number of Diagnostic Centers, and Locations.
Table 15-1: Future Outlook for India Private Diagnostic Laboratories Market, FY'2017-FY'2021
Table 15-2: India Private Diagnostic Laboratories Market Segmentation Future Outlook and Projection by Pathology and Radiology Tests on the Basis of Revenue in INR Crore, FY'2017-FY'2021
Table 15-3: India Private Diagnostic Laboratories Market Segmentation Future Outlook and Projection by Tier I, Tier II and Tier III Cities on the Basis of Revenue in INR Crore, FY'2017-FY'2021
Table 15-4: India Private Diagnostic Laboratories Market Segmentation Future Outlook and Projection Tier I, Tier II and Tier III Cities on the Basis of Revenue in INR Crore, FY'2017-FY'2021
Table 16-1: Analyst Recommendations for India Private Diagnostic Laboratories Market
Table 17-1: Rationale for Per Capita Healthcare Spending in India, 2011 - 2021
Table 17-2: Rationale for Ageing Population in India, 2011 - 2021
Table 17-3: Rationale for Number of Births in India, 2011-2021
Table 17-4: Rationale for Medical Tourism Market in India, FY'2011-FY'2021

Single User License:
Access to the soft copy of the report will be granted to individual user/ Authorized User within the organization The Authorized User may store, display or archive the information but will not be able to print, copy and use any information in the report for circulation or citation purpose. The individual user will treat the information in the report as confidential and will only use this for internal purpose. In no circumstance, the complete / part of the publication may be resold for monetary terms by the client or any other party related to the client or can be made available on third party website or on Google for general public view. The report will be MAC address protected and will only be accessible on 1 platform.

Hard Copy License:
The license provides the access to hard copy/ printed copy of the report to the Authorized User only. The report will be delivered to the user on the address provided during making the purchase. The Authorized User may store, display, or archive the information but will not use any information in the report for circulation or citation purpose. The individual user will treat the information in the report as confidential and will only use this for internal purpose. In no circumstance, the complete / part of the publication may be resold for monetary terms by the client or any other party related to the client or can be made available on third party website or on Google for general public view. No soft copy access will be provided in this case.

Corporate User License:
Access to the soft copy of the report will be granted to multiple users within the organization. The users are authorized to store, display, duplicate, archive, print and distribute the information within the organization either electronically or in paper. The users are not authorized to use any information in the report for citation and circulation externally. The users will treat the information in the report as confidential and will only use this for internal purpose. In no circumstance, the complete / part of the publication may be resold for monetary terms by the client or any other party related to the client or can be made available on third party website or on Google for general public view.

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

SRL Diagnostics, Dr Lal PathLabs, Thyrocare, Metropolis Healthcare Limited, BSR Healthcare, Medall Healthcare, Apollo Diagnostics, Oncquest Laboratories Limited, Suburban Diagnostics, Vijaya Diagnostic Center, Lucid Medical Diagnostics, BSR Healthcare, PathCare, Star Imaging & Path Lab Pvt. Ltd., Atulya Healthcare, Suraksha, Express Clinics, Krsnaa Diagnostics, Cryogenex Diagnostics Pvt. Ltd.

Pathology Services, Molecular Biology, Clinical Microbiology, Histopathology, Hematology, Surgical Pathology, Clinical Biochemistry, Radiology Services, X-RAY, Sonography, MRI, CT Scan, Mammography, PET/SPECT


Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com